发明名称 Prodefensin-A6 assay method for the in vitro diagnosis of colorectal cancer
摘要 The present invention relates to a method for the in vitro diagnosis of colorectal cancer by determining the presence of the Prodefensin-A6 tumour marker in a biological sample taken from a patient suspected of having colorectal cancer, it being possible for said method to be used both in early diagnosis, screening, therapeutic follow-up and prognosis, and in relapse diagnosis in relation to colorectal cancer.
申请公布号 US9062099(B2) 申请公布日期 2015.06.23
申请号 US201013260854 申请日期 2010.04.01
申请人 BIOMERIEUX 发明人 Ataman-Önal Yasemin;Beaulieu Corinne;Busseret Sandrine;Charrier Jean-Philippe;Choquet-Kastylevsky Geneviève;Rolland Dominique
分类号 G01N33/53;C07K16/18;C07K16/30;G01N33/574 主分类号 G01N33/53
代理机构 Oliff PLC 代理人 Oliff PLC
主权项 1. An in vitro method for diagnosing colorectal cancer using a biological sample obtained from a patient suspected of having colorectal cancer, comprising: assaying for the level of the Prodefensin-A6 protein present in the biological sample using at least one antibody or antibody fraction specific for the Prodefensin-A6 protein; and determining whether the level of the Prodefensin-A6 protein is indicative of the patient having colorectal cancer, wherein the level of the Prodefensin-A6 protein is assayed by detecting any of the signal peptide or the propeptide of the Prodefensin-A6 protein, whether as part of the intact Prodefensin-A6 protein or a fragment thereof, to the exclusion of the mature Defensin-A6 protein or fragments of the mature Defensin-A6 protein.
地址 Marcy l'Etoile FR